Vault compositions for immunization against Chlamydia genital infection
View Patent ↗Methods and compositions are provided herein for immunizing a subject against Chlamydial genital infection by administering to the subject an effective amount of a Chlamydial immunogenic peptide or an immunogenic fragment or variant thereof incorporated within a vault-like particle carrier. In some aspects, the vault-like-particles are administered to the nasal mucosa. The methods and compositions advantageously exhibit enhanced ability to induce cell-mediated immunity and/or antibody-based immunity at mucosal surfaces while reducing inflammation associated with Chlamydia infection.
1. A method of treating Chlamydial infection in a subject, comprising administering to the subject an effective amount of a Chlamydial immunogenic peptide or an immunogenic fragment or variant thereof incorporated within a vault-like particle, wherein the vault-like particle comprises MVP.
2. The method of claim 1 , wherein the immunogenic peptide is MOMP.
3. The method of claim 1 , wherein the vaults provided are purified from natural sources.
4. The method of claim 1 , wherein the vaults provided are generated using recombinant technology.
5. The method of claim 1 , wherein the immunogenic peptide is incorporated in the vault-like-particle by incubating vaults with the immunogenic peptide or immunogenic fragment or variant thereof.
6. The method of claim 1 , wherein the vault-like particle further comprises VPARP or modified VPARP, or a portion of VPARP, or a modified portion of VPARP.
7. The method of claim 1 , wherein the MVP is modified by the addition of an amino acid sequence added to the N-terminal of the MVP.
8. The method of claim 1 , wherein the MVP is modified by the addition of an amino acid sequence added to the C-terminal of the MVP.
9. The method of claim 7 , wherein the immunogenic peptide or immunogenic fragment or variant thereof resides within the vault-like particle.
10. A method of immunizing a subject against Chlamydial genital infection, comprising administering to the subject an effective amount of a Chlamydial immunogenic peptide or an immunogenic fragment or variant thereof incorporated within a vault-like particle, wherein the vault-like particle comprises MVP.
11. The method of claim 10 , wherein the immunogenic peptide is MOMP.
12. The method of claim 10 , wherein the vault-like particle further comprises VPARP or modified VPARP, or a portion of VPARP, or a modified portion of VPARP.
13. The method of claim 10 , wherein the MVP is modified by the addition of an amino acid sequence added to the N-terminal of the MVP.
14. The method of claim 13 , wherein the immunogenic peptide or immunogenic fragment or variant thereof resides within the vault-like particle.
15. The method of claim 10 , wherein the MVP is modified by the addition of an amino acid sequence added to the C-terminal of the MVP.